• OPEN AN ACCOUNT
Indian Indices
Nifty
25,103.20 100.15
(0.40%)
Sensex
82,543.87 98.66
( 0.12%)
Bank Nifty
56,839.60 261.20
( 0.46%)
Nifty IT
37,669.20 374.35
( 1.00%)
Global Indices
Nasdaq
42,777.23 -6.65
(-0.02%)
Dow Jones
6,025.66 4.30
(0.07%)
Hang Seng
38,084.54 342.93
(0.91%)
Nikkei 225
8,832.28 -5.63
(-0.06%)
Forex
USD-INR
85.75 -0.02
(-0.02%)
EUR-INR
97.72 -0.17
(-0.18%)
GBP-INR
115.95 -0.20
(-0.17%)
JPY-INR
0.59 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
411.1031908
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
57.21
1138.33
EPS(TTM)
Face Value()
Div & Yield %
33.77
10
0
 

Colab Platforms consolidated net profit rises 375.00% in the March 2025 quarter
May 30,2025
Net profit of Colab Platforms rose 375.00% to Rs 0.95 crore in the quarter ended March 2025 as against Rs 0.20 crore during the previous quarter ended March 2024. Sales rose 18472.73% to Rs 20.43 crore in the quarter ended March 2025 as against Rs 0.11 crore during the previous quarter ended March 2024.

For the full year,net profit rose 59.78% to Rs 2.86 crore in the year ended March 2025 as against Rs 1.79 crore during the previous year ended March 2024. Sales rose 4241.51% to Rs 69.03 crore in the year ended March 2025 as against Rs 1.59 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales20.430.11 18473 69.031.59 4242
OPM %5.8236.36 -3.1070.44 -
PBDT1.250.20 525 3.171.79 77
PBT1.240.19 553 3.151.78 77
NP0.950.20 375 2.861.79 60